Agenda

Introduction

Pemvidutide for Obesity and its Comorbidities

Pemvidutide for MASH: Upcoming Phase 2b Readout

Introducing Two Additional High-Impact Indications

• Alcohol Use Disorder (AUD)
• Alcohol Liver Disease (ALD)

Summary